NEW YORK (GenomeWeb News) - Laboratory Corporation of America will use Affymetrix’s genotyping tools in a molecular cytogenetic service it will offer to US researchers, Affy said today.

 

Under the agreement, LabCorp will use Affy’s GeneChip technology in an offering that its customers can use to “correlate deletions, gains and other chromosomal rearrangements with congenital diseases such as autism, mental retardation and development delay in children,” the company said.